切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2018, Vol. 12 ›› Issue (01) : 61 -64. doi: 10.3877/cma.j.issn.1674-0793.2018.01.017

所属专题: 文献

综述

复杂乳腺纤维腺瘤的诊断及治疗
李雄雄1, 朱丽喆1, 周灿1, 任予1,()   
  1. 1. 710061 西安交通大学第一附属医院乳腺外科
  • 收稿日期:2017-06-30 出版日期:2018-02-01
  • 通信作者: 任予

Diagnosis and treatment of complex fibroadenoma

Xiongxiong Li1, Lizhe Zhu1, Can Zhou1, Yu Ren1,()   

  1. 1. Department of Breast Surgery, the First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China
  • Received:2017-06-30 Published:2018-02-01
  • Corresponding author: Yu Ren
  • About author:
    Corresponding author: Ren Yu, Email:
引用本文:

李雄雄, 朱丽喆, 周灿, 任予. 复杂乳腺纤维腺瘤的诊断及治疗[J/OL]. 中华普通外科学文献(电子版), 2018, 12(01): 61-64.

Xiongxiong Li, Lizhe Zhu, Can Zhou, Yu Ren. Diagnosis and treatment of complex fibroadenoma[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2018, 12(01): 61-64.

我国乳腺癌发病率呈快速上升趋势,在引起乳腺癌的众多危险因素中,乳腺纤维腺瘤与乳腺癌有无相关一直是争论的焦点,尤其是复杂乳腺纤维腺瘤。本研究主要围绕复杂乳腺纤维腺瘤的癌变率、诊断和治疗做一综述,为临床医师正确处理乳腺纤维腺瘤提供证据。

The prevalence of breast malignancy has been increasing rapidly in China nowadays. Among the numerous inducements of breast cancer, whether fibroadenoma related to breast cancer has been the controversy, especially for complex fibroadenoma. This article mainly focuses on the risk of developing breast carcinoma, the diagnosis and treatment of complex fibroadenoma, providing evidence for the correct treatment of breast fibroadenoma.

[1]
Dupont WD, Page DL, Parl FF, et al. Long-term risk of breast cancer in women with fibroadenoma[J]. N Engl J Med, 1994, 331(1): 10-15.
[2]
Greenberg R, Skornick Y, Kaplan O, et al. Management of breast fibroadenomas[J]. J Gen Intern Med, 1998,13(9): 640-645.
[3]
Cant PJ, Madden MV, Coleman MG, et al.Non-operative management of breast masses diagnosed as fibroadenoma[J]. Br J Surg, 1995,82(6): 792-794.
[4]
El-Wakeel H, Umpleby HC. Systematic review of fibroadenoma as a risk factor for breast cancer[J]. Breast, 2003,12(5): 302-307.
[5]
Nassar A, Visscher DW, Degnim AC, et al. Complex fibroadenoma and breast cancer risk: a Mayo Clinic Benign Breast Disease Cohort Study[J]. Breast Cancer Res Treat, 2015, 153(2): 397-405.
[6]
Kabat GC, Jones JG, Olson N, et al. A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer[J]. Cancer Causes Control, 2010,21(6): 821-828.
[7]
Kuijper A, Mommers EC, van der Wall E, et al. Histopathology of fibroadenoma of the breast[J]. Clin Pathol, 2001,115(6): 736-742.
[8]
Sklair-Levy M, Sella T, Alweiss T, et al. Incidence and management of complex fibroadenomas[J]. AJR Am J Roentgenol, 2008,190(1): 214-218.
[9]
Lim WK, Ong CK, Tan J, et al. Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma[J]. Nat Genet, 2014,46(8): 877-880.
[10]
Kalderon AE, Diner WC. Carcinoma arising in a long-standing fibroadenoma[J]. Am J Diagn Gynecol Obstet, 1979,1(3): 269-273.
[11]
Pick PW, Iossifides IA. Occurrence of breast carcinoma within a fibroadenoma. A review[J]. Arch Pathol Lab Med, 1984,108(7): 590-594.
[12]
Shinde SR, Jussawalla DJ. Lobular carcinoma arising in a fibroadenoma[J]. Surg Oncol, 1982, 20(1): 59-61.
[13]
Schnitt SJ. Benign breast disease and breast cancer risk: morphology and beyond[J]. Am J Surg Pathol, 2003,27(6): 836-841.
[14]
Leconte I, Abraham C, Galant C, et al. Fibroadenoma: can fine needle aspiration biopsy avoid short term follow-up?[J]. Diagn Interv Imaging, 2012, 93(10): 750-756.
[15]
Pinto J, Aguiar AT, Duarte H, et al. Simple and complex fibroadenomas:are there any distinguishing sonographic features?[J]. Ultrasound Med, 2014, 33(3): 415-419.
[16]
Lee KH, Kim SJ, Park YM, et al. Gray-scale and color Doppler sonographic features of complex fibroadenomas of the breast[J]. J Clin Ultrasound, 2015,43(9): 556-562.
[17]
National Comprehensive Cancer Network. Breast cancer screening and diagnosis[EB/OL].[2013-12-02].

URL    
[18]
Cant PJ, Madden MV, Close PM, et al. Case for conservative management of selected fibro-adenomas of the breast[J]. Br J Surg, 1987, 74(9): 857-859.
[19]
Marcon M, Frauenfelder T, Beckera AS, et al. First ultrasound diagnosis of BI-RADS 3 lesions in young patients: Can 6-months follow-up be sufficient to assess stability?[J]. Eur J Radiol, 2017, 89: 226-233.
[20]
Gordon PB. Solid breast masses diagnosed as fibroadenoma at fine-needle aspiration biopsy: acceptable rates of growth at long-term follow-up[J]. Radiology, 2003,229(1): 233-238.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[3] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[4] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[5] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[6] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[7] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[8] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[9] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[10] 葛睿, 陈飞, 李杰, 李娟娟, 陈涵. 多基因检测在早期乳腺癌辅助治疗中的应用价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 257-263.
[11] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[12] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[13] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[14] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[15] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?